Finance

Beta
Lists
ARE:NYSE
Alexandria Real Estate Equities, Inc
$52.52
-0.92%
(-0.49) 1D
Jul 2, 10:56:54 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARE...
Open
$53.48
High
$53.73
Low
$52.52
Mkt. cap
9.16B
Avg. vol.
1.99M
Volume
356.75K
Dividend
6.63%
Quarterly dividend
$0.87
Ex-dividend date
Jun 30, 2026
52-wk high
$88.24
52-wk low
$39.41
EPS
-$6.27
Beta
1.17
Shares outstanding
174.27M
No. of employees
514
Open
$53.48
High
$53.73
Low
$52.52
Mkt. cap
9.16B
Avg. vol.
1.99M
Volume
356.75K
Dividend
6.63%
Quarterly dividend
$0.87
Ex-dividend date
Jun 30, 2026
52-wk high
$88.24
52-wk low
$39.41
EPS
-$6.27
Beta
1.17
Shares outstanding
174.27M
No. of employees
514
News stories
From sources across the web
Profile
Alexandria Real Estate Equities, Inc. is a real estate investment trust based in Pasadena, California that invests in office buildings and laboratories leased to tenants in the life science and technology industries. Properties are generally located near universities to attract tenants. The company owns several major technology/biotechnology office campuses including the 740,972 square foot Alexandria Center for Life Science in Manhattan, and the 2,365,487 square foot Alexandria Center at Kendall Square and the 1,181,635 square foot Technology Square in the Boston area. The company is dependent on the life sciences industry and funding for research by the United States Government. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms. The company is named after Alexandria, Egypt because of that city's connection to science. Wikipedia
About Alexandria Real Estate Equities, Inc
CEOPeter M. Moglia
Employees514
FoundedJan 1, 1994
HeadquartersPasadena, California, United States
SectorReal estate investment trust
Websiteare.com
Analyst ratings
Based on 10 analysts giving stock ratings to ARE in the past 3 months
Hold
Buy
2
Hold
7
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for ARE in the last 3 months.
Highest
Current $52.52
$58.00 (+10.43%)
Average
$50.22 (-4.38%)
Lowest
$42.00 (-20.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Spector
Bank of America Securities
Hold
Maintained
$54.00
+2.8%
06/26/2026
John Kim
BMO Capital
Hold
Maintained
$54.00
+2.8%
06/12/2026
Ronald Kamdem
Morgan Stanley
Sell
Downgraded
$53.00
+0.9%
06/11/2026
James Kammert
Evercore ISI
Buy
Maintained
$58.00
+10.4%
06/08/2026
Farrell Granath
Bank of America Securities
Hold
Maintained
$50.00
-4.8%
05/22/2026
Julien Blouin
Goldman Sachs
Hold
Maintained
$52.00
-1%
05/19/2026
Michael Carroll
RBC Capital
Hold
Maintained
$50.00
-4.8%
05/04/2026
Wes Golladay
Robert W. Baird
Hold
Downgraded
$46.00
-12.4%
05/04/2026
Nicholas Joseph
Citi
Hold
Reiterated
$42.00
-20%
05/01/2026
Richard Anderson
Cantor Fitzgerald
Hold
Maintained
$43.00
-18.1%
04/29/2026
Michael Tupholme
TD Cowen
Buy
Maintained
-
-
04/27/2026
Anthony Paolone
J.P. Morgan
Hold
Maintained
$57.00
+8.5%
03/10/2026
Jonathan Petersen
Jefferies
Hold
Maintained
$57.00
+8.5%
01/30/2026
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.10 / $0.17
+1,135.29%beat
Revenue / Est. (USD)
671.02M / 695.55M
-3.53%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
753.02M
752.14M
754.11M
670.88M
Cost of goods sold
224.43M
239.23M
232.54M
224.14M
Cost of revenue
224.43M
239.23M
232.54M
224.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.13M
29.22M
28.02M
34.68M
Operating expense
375.25M
369.45M
350.08M
340.13M
Total operating expenses
599.68M
608.69M
582.63M
564.27M
Operating income
153.34M
143.46M
171.48M
106.61M
Other non operating income
-
-
-
-
EBT including unusual items
-62.19M
-197.84M
-995.35M
398.38M
EBT excluding unusual items
98.04M
116.77M
105.81M
42.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-107.00M
-232.75M
-1.08B
361.65M
Net profit margin
-14.21%
-30.95%
-143.33%
53.91%
Earnings per share
0.48
0.50
-
-
Interest and investment income
-
28.16M
-
-
Interest expense
-55.30M
-54.85M
-65.67M
-64.58M
Net interest expenses
-55.30M
-26.69M
-65.67M
-64.58M
Depreciation and amortization charges
346.12M
340.23M
322.06M
305.44M
EBITDA
489.26M
477.23M
487.66M
406.43M
Gain or loss from assets sale
-
-9.37M
-619.91M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer